Adis

Adis Journal Podcasts

Science EN ↓ 132 episodes

Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.

Be sure to visit the podcast's website and support the creator: podcastb063dc.podigee.io

Author

Adis

Category

Science

Podcast website

podcastb063dc.podigee.io

Latest episode

Nov 16, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast 22.03.2024

Authors Dr Peter Black and Dr Bernie Eigl aim to provide an overview of the non-muscle-invasive bladder cancer (NMIBC) landscape with a focus on high-risk NMIBC. This includes understanding the diagnosis and current treatment approaches with a focus on the medical needs and high-risk NMIBC treatment, highlighting the potential challenges associated with the introduction of programmed cell death li...

Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example 22.03.2024

In this podcast, author Dr Kai Hübel discussed a case of a patient with high-risk relapse follicular lymphoma. This discussion outlines the potential effectiveness of chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory follicular lymphoma. This podcast is adapted from a vodcast article published open access in Oncology and Therapy and is fully citeable. The vodcast article featur...

Inotuzumab in Older Patients with Newly Diagnosed Acute Lymphoblastic Leukemia — A Podcast 08.03.2024

In this podcast, Elias Jabbour from the University of Texas MD Anderson Cancer Center, Houston, TX, and Matthias Stelljes from the Universitätsklinikum Münster, Münster, Germany summarize and highlight some of the recent findings on the use of inotuzumab ozogamicin as induction therapy for older adults with newly diagnosed acute lymphoblastic leukemia (ALL). This peer-reviewed podcast is published...

A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast 04.03.2024

This podcast is published open access in Ophthalmology and Therapy and is fully citeable. You can access the original published podcast article through the Ophthalmology and Therapy website and by using this link. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-co...

Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases 08.02.2024

This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s13555-023-01093-w. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonComm...

A Podcast on the Use of CGM in Optimizing Type 2 Diabetes Management with Non-intensive Insulin Treatment in the Primary Care Setting 15.01.2024

In this podcast, we are joined by Professor Sam Seidu who discusses the potential of continuous glucose monitoring (CGM) in managing type 2 diabetes with non-intensive insulin treatment in primary care. This includes a discussion on the evidence for CGM use, the role of primary healthcare in diabetes management, and some practical tips for interpreting the Ambulatory Glucose Profile (AGP) report....

Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health 24.11.2023

This podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40121-023-00885-z. All conflicts of interest can be found online.   Open Access This podcast is licensed under a Creative Commons A...

Podcast on Identifying and Understanding Barriers to Care in Undeserved Populations With MS in the United States 21.11.2023

This podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United States | Neurology and Therapy (springer.com). All conflicts of interest can be found o...

Podcast on Self-administered Intranasal Etripamil for Symptomatic Paroxysmal Supraventricular Tachycardia: The RAPID Trial 15.11.2023

In this podcast, Dr Lip and Dr Stambler discuss the RAPID trial (NCT03464019), which was a phase 3 study that evaluated the safety and efficacy of etripamil in terminating PSVT episodes using a repeat-dosing regimen. RAPID was a multicenter, randomized trial that enrolled adults with electrocardiograph (ECG)-documented PSVT episodes lasting ≥ 20 min. This podcast is published open access in Cardio...

EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast 04.10.2023

In this podcast, Xiuning Le from the University of Texas MD Anderson Cancer Center, Houston, TX, Eric Nadler from the Baylor University Medical Center, Dallas, TX, Daniel Costa from the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, and John Heymach from the University of Texas MD Anderson Cancer Center, Houston, TX discuss the use of EGFR tyrosine kinase inhibitors for...

Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast 03.10.2023

This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-023-02664-1. All conflicts of interest can be found online.   Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial...

Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies 27.09.2023

This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies | Advances in Therapy (springer.com). All conflicts of interest can be found online.   Open A...

EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists 27.09.2023

In this podcast, two oncologists and two patient advocates from the patient advocacy group EGFR Resisters talk about the importance of biomarker testing for patients with non-small cell lung cancer and how this can affect treatment decisions and personalised medicine. The panel discusses what biomarkers are, the processes involved in obtaining biomarker testing, how biomarker information is used,...

Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy) 20.09.2023

  This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy) | Advances in Therapy (springer.com). All conflict...

Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast 15.09.2023

In this podcast, a healthcare professional discusses germline genetic testing with a patient advocate and answers questions regarding the importance of testing in patients with metastatic breast cancer, with a specific focus on germline or inherited breast cancer susceptibility gene (BRCA) mutations. In the USA, national guidelines recommend that all patients with recurrent or metastatic breast ca...

Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis 14.08.2023

Brain metastases are especially common in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with a cumulative incidence of over 50% and associated with a poor prognosis, high symptom burden, and decreased quality of life. In this podcast, authors discuss the clinical significance of controlling the onset of brain metastases, considerations in selecting a first-line ther...

How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast 27.06.2023

This podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast | SpringerLink All conflicts of interest can be found online.   Open Access This podcast is licensed under a Creative Common...

Podcast on the Challenges and Recommendations to Address Unmet Needs in MS for LGBTQ+ Populations in the United States 27.06.2023

This podcast is published open access in NETH and is fully citeable. You can access the original published podcast article through the NETH website and by using this link: https://link.springer.com/article/10.1007/s40120-023-00506-4  All conflicts of interest can be found online.   Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, wh...

Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast 20.06.2023

 In this podcast, the authors summarize and highlight some of the T cell–redirecting bispecific antibodies (BsAb) currently in development for the treatment of relapsed/refractory multiple myeloma with a focus on the data reported at the oral session for BsAb at the American Society of Hematology’s 2022 meeting from clinical phase 1 and 2 studies. The six presentations reported the latest safety a...

Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast 13.06.2023

In this podcast, experts discuss the challenges for implementing vaccine recommendations for individuals with medical conditions at increased risk of developing meningococcal disease. Strategies to increase vaccine coverage are also discussed.     This podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article th...

Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast 07.06.2023

In this plain language podcast, highlights from the European Society for Medical Oncology (ESMO) Congress are discussed for a second year in a row, from the perspective of both a patient advocate and a healthcare professional. Here, the authors discuss the importance of involving patients in the design of clinical trials, as well as strategies to improve dialogue and connections between clinicians...

Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor 31.05.2023

This podcast covers topics including the metastatic renal cell carcinoma landscape with a focus on immune-oncology (IO) agents and tyrosine kinase inhibitors, axitinib indication (combination and monotherapy), a summary of efficacy and safety data, dose modification guidelines, and author experience of managing patients with the most common adverse events (AEs) encompassing prior to initiating the...

P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2− Metastatic Breast Cancer—A Podcast 06.05.2023

In this podcast, Adam Brufsky from the UPMC Hillman Cancer Center, Magee-Women’s Hospital, University of Pittsburgh Medical Center in Pittsburgh, and Christopher Gallagher from the Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC discuss how real-world data in heterogeneous patient populations can complement clinical trial data in informing treatment decision making...

HER2-Low Breast Cancer—Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast 03.05.2023

In this podcast, Aditya Bardia from the Massachusetts General Hospital, Harvard Medical School in Boston, and Giuseppe Viale from the Department of Pathology and Laboratory Medicine at the European Institute of Oncology in Milan discuss HER2-low breast cancer, including the implications of the recent US FDA and EU approval of trastuzumab deruxtecan (T-DXd) for use in patients with HER2-low breast...

Podcast on the Art of the Patient Conversation: Healthcare Provider Perspectives to Improve Outcomes in Multiple Sclerosis 14.03.2023

In this podcast article, nurse practitioners discuss multimodal strategies that enable appropriate conversations to meet patients’ needs through the following four techniques: patient-centric language, teach-back, open-ended questions, and active listening and paraphrasing. These techniques are incorporated into example patient–provider conversations to demonstrate their effectiveness in clinical...

Listen to the Adis Journal Podcasts podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.